145155-23-3 Usage
Description
Interferon beta-1b, also known as Betaseron, is a protein expressed in a recombinant E. coli and is equivalent in type to the interferon expressed by human fibroblasts. It is a stable analog of human interferon-beta produced by recombinant DNA technique and is the first biotechnology product licensed under the FDA's accelerated approval regulation. Interferon beta-1b possesses antiviral and immunomodulating activities, making it a promising pharmaceutical candidate for various applications.
Uses
Used in Pharmaceutical Industry:
Interferon beta-1b is used as an immunomodulator for the treatment of relapsing-remitting multiple sclerosis (RRMS). It helps decrease the frequency of clinical exacerbation in ambulatory patients with RRMS, a condition characterized by unpredictable attacks resulting in neurological deficits, separated by variable periods of remission.
Interferon beta-1b is also used as a therapeutic agent for its potential in treating melanoma, renal cell carcinoma, genital warts, hepatitis, rhinovirus, and several types of malignant tumors. It demonstrates immunoregulatory properties, including decreasing T-cell proliferation, blocking the synthesis of interferon-gamma that may be involved in MS, inhibiting the release of other cytokines that damage oligodendrocytes, and increasing T suppressor-cell activity.
Brand names for interferon beta-1b include Betaseron (Berlex) and Betaseron.
Originator
Chiron (U.S.A.)
Check Digit Verification of cas no
The CAS Registry Mumber 145155-23-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,5,1,5 and 5 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 145155-23:
(8*1)+(7*4)+(6*5)+(5*1)+(4*5)+(3*5)+(2*2)+(1*3)=113
113 % 10 = 3
So 145155-23-3 is a valid CAS Registry Number.